Aug 12, 2026 07:30AM
Jul 14, 2026 06:44AM
May 12, 2026 08:30AM
Apr 17, 2026 04:01PM
Apr 17, 2026 04:01PM
Apr 14, 2026 07:01AM
Apr 14, 2026 07:00AM Adagene Adds Industry Veteran Peter Lebowitz to Scientific and Strategic Advisory Board
Apr 7, 2026 07:49AM
Apr 2, 2026 07:01AM
Apr 2, 2026 07:01AM
Apr 2, 2026 07:00AM
Apr 2, 2026 07:00AM
Apr 1, 2026 05:00PM
Mar 17, 2026 04:35PM Adagene’s Muzastotug (ADG126) to be Highlighted in Two Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting in San Diego, CA
Mar 10, 2026 05:31PM
Feb 17, 2026 09:27AM
Jan 23, 2026 08:00AM
Dec 16, 2025 07:00AM
Dec 16, 2025 07:00AM
Oct 31, 2025 07:00AM
Oct 31, 2025 07:00AM Adagene Announces First Patient Dosed in Randomized Dose Optimization Cohort of the Phase 2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorec
Sep 3, 2025 09:05AM
Sep 3, 2025 09:05AM
Aug 15, 2025 06:53AM
Aug 12, 2025 04:05PM
Jul 15, 2025 07:01AM
Jul 15, 2025 07:00AM
Mar 24, 2025 08:00AM Adagene Reports Full Year 2024 Financial Results and Provides Corporate Update
Sep 16, 2024 03:01AM
Feb 9, 2024 06:01AM
Feb 9, 2024 06:00AM
Jan 9, 2023 07:02AM
Jan 9, 2023 07:00AM
Jan 9, 2023 07:00AM
Dec 16, 2022 06:32AM Adagene Inc. (ADAG) Announces Clinical Trial Collaboration for ADG126
Dec 16, 2022 06:30AM
Dec 16, 2022 06:30AM
Mar 31, 2022 08:30AM
Mar 31, 2022 08:30AM
Mar 16, 2022 07:00AM
Mar 16, 2022 07:00AM
Feb 2, 2022 04:23PM Adagene Inc. (ADAG) Announces Board and Management Appointments
Feb 2, 2022 04:05PM
Nov 30, 2021 09:28AM
Nov 29, 2021 06:03PM
Nov 29, 2021 04:06PM
Nov 29, 2021 04:05PM
Aug 26, 2021 07:45AM
Aug 26, 2021 07:45AM Adagene Reports Financial Results for the Six Months Ended June 30, 2021 and Provides Corporate Updates
Aug 12, 2021 07:45AM

328,342 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All